BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Alenzi M, Almeqdadi M. Bridging the gap: Addressing disparities in hepatitis C screening, access to care, and treatment outcomes. World J Hepatol 2024; 16(8): 1091-1098 [PMID: 39221096 DOI: 10.4254/wjh.v16.i8.1091]
URL: https://www.wjgnet.com/1007-9327/full/v16/i8/1091.htm
Number Citing Articles
1
Gianluca Azzellino, Lia Ginaldi, Massimo De Martinis. A Biosocial Roadmap to Tackle the Burden of Hepatitis C Virus Infections That Ensures Health Equity for AllClinical Infectious Diseases 2025; 81(1): e6 doi: 10.1093/cid/ciae623
2
Pietro Torre, Mariano Festa, Tommaso Sarcina, Mario Masarone, Marcello Persico. Elimination of HCV Infection: Recent Epidemiological Findings, Barriers, and Strategies for the Coming YearsViruses 2024; 16(11): 1792 doi: 10.3390/v16111792
3
Chieu‐Hoang Ly Luong, Lisa Kalisch Ellett, Nicole Pratt, Kirsten Staff, Jack Janetzki. Trends in Use of Direct‐Acting Antivirals for Treatment of Hepatitis C Virus Infection in Australia 2016–2024Journal of Viral Hepatitis 2025; 32(10) doi: 10.1111/jvh.70082
4
Dana Ivancovsky Wajcman, Aina Nicolàs, Camila A. Picchio, Lena van Selm, Geoffrey Dusheiko, Zobair M. Younossi, John F. Dillon, Saleh A. Alqahtani, Homie Razavi, Massimo G. Colombo, Achim Kautz, Gregory J. Dore, Jeffrey V. Lazarus. Prioritising viral hepatitis elimination to prevent hepatocellular carcinoma: A public health approach for effective preventive hepatologyJHEP Reports 2025; 7(8): 101436 doi: 10.1016/j.jhepr.2025.101436